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ABSTRACT – Background - Postoperative liver failure consequent to insufficiency of 
remnant liver is a feared complication in patients who underwent extensive liver 
resections. To induce rapid and significant hepatic hypertrophy, associating liver 
partition and portal vein ligation for staged hepatectomy (ALPPS) has been recently 
developed for patients which tumor is previously considered unresectable. Aim – To 
present the Brazilian experience with ALPPS approach. Method – Were analyzed 
39 patients who underwent hepatic resection using ALPPS in nine hospitals. The 
procedure was performed in two steps. The first operation was portal vein ligation 
and in situ splitting. In the second operation the right hepatic artery, right bile duct 
and the right hepatic vein were isolated and ligated. The extended right lobe was 
removed. There were 22 male (56.4%) and 17 female (43.6%). At the time of the 
first operation, the median age was 57.3 years (range: 20-83 years). Results - The 
most common indication was liver metastasis in 32 patients (82.0%), followed by 
cholangiocarcinoma in three (7.7%). Two patients died (5.2%) during this period and 
did not undergo the second operation. The mean interval between the first and the 
second operation was 14.1 days (range: 5-30 days). The volume of the left lateral 
segment of the liver increased 83% (range 47-211.9%). Significant morbidity after 
ALPPS was seen in 23 patients (59.0%). The mortality rate was 12.8% (five patients). 
Conclusion – The ALPPS approach can enable resection in patients with lesions 
previously considered unresectable. It induces rapid liver hypertrophy avoiding liver 
failure in most patients. However still has high morbidity and mortality.
RESUMO – Racional – Insuficiência hepática pós-operatória devido à remanescente 
hepático pequeno tem sido complicação temida em pacientes que são submetidos à 
ressecção hepática extensa. A ligadura da veia porta associada à bipartição do fígado 
para hepatectomia em dois estágios (ALPPS) foi desenvolvida recentemente com a 
finalidade de induzir rápida e significante regeneração do fígado para pacientes 
em que o tumor é previamente considerado irressecável. Objetivo – Apresentar 
a experiência brasileira com o ALPPS. Método – Foram analisados 39 pacientes 
submetidos ao procedimento ALPPS em nove hospitais. Ele foi realizado em duas 
etapas. A primeira operação consistiu em ligadura do ramo direito da veia porta e 
bipartição hepática. Na segunda, os ramos direito da artéria hepática, via biliar e 
veia hepática foram ligados e o lobo hepático direito estendido foi removido. Foram 
22 pacientes do sexo masculino (56,4%) e 17 do feminino (43,6%). A média de idade 
foi 57,3 anos (variando de 20 a 83 anos). Resultados – A indicação mais comum 
foi metástase hepática em 32 pacientes (82,0%), seguida por colangiocarcinoma 
em três pacientes (7,7%). Dois morreram neste intervalo e não foram submetidos 
à segunda operação. O intervalo médio da primeira para a segunda operação 
foi de 14,1 dias (variando de 5-30 dias). O volume do segmento lateral esquerdo 
apresentou aumento de 83% (variando de 47-211,9%). Morbidade significante foi 
observada em 23 pacientes (59,0%). A mortalidade foi de 12,8% (cinco pacientes). 
Conclusão – O procedimento ALPPS permite ressecção hepática em pacientes 
com lesões consideradas previamente irressecáveis por induzir rápida hipertrofia 
do fígado evitando a insuficiência hepática na maioria dos pacientes. Porém ainda 
apresenta elevada morbidade e mortalidade.
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INTRODUTION
In patients with primary or metastatic hepatic disease, resection is the only potentially curative therapeutic option. The remaining 
liver volume is one very important limiting factor to 
perform major liver resections. Postoperative hepatic 
insufficiency is a serious complication in these 
patients who underwent extensive hepatic resections. 
Avoiding this lethal complication remains a challenge 
for hepatobiliary surgeons5,20,22.
For patients with normal liver, the future liver 
remnant to prevent postoperative liver failure should 
be at least 25% of total liver volume. In patients 
with hepatic dysfunction or earlier liver injury due 
to chemotherapy, a higher future liver remnant is 
recommended18,20,21,22.
Some strategies have been developed to 
increase resectability in patients undergoing major 
hepatic resection. The induction of liver hypertrophy 
by occlusion of portal vein can be done through 
embolization by radiology or surgically. This approach 
is able to induce atrophy of the tumor-bearing lobe 
with subsequent hypertrophy in the contralateral 
lobe by diverting the portal venous flow. Portal vein 
occlusion is able to increase the future liver remnant 
up to 40% within three to eight weeks. In some 
patients however, sufficient hypertrophy is not always 
achieved, and there is still concern about the potential 
for faster growth of the tumor during the period prior 
to resection2,3,4,7,11.
Schnitzbauer et al.17 in Germany developed a new 
two-step technique consisting on the combination of 
partition of liver parenchyma with portal vein ligation 
in order to improve resectability. De Santibanes and 
Clavien have proposed to rename it “associating 
liver partition and portal vein ligation for staged 
hepatectomy” (ALPPS).  This technique has been used 
around the world with excellent results 14,15,16,17.
The aim of this study is to present the Brazilian 
experience with ALPPS for the treatment of patients 
with initially unresectable primary and metastatic 
liver tumors. 
METHOD 
The clinical records of all patients who underwent 
hepatic resection using ALPPS procedure in nine 
hospitals were reviewed. In the period between July 
2011 and October 2012, 39 patients underwent liver 
resection with ALPPS technique in nine different 
hospitals in Brazil. Before resection all patients 
underwent radiologic evaluation with a 3-phase 
intravenous contrast CT scan of the abdomen and were 
considered unresectable or marginally resectable. 
The surgical technique has been previously 
reported and was performed in two steps19. After 
exploratory laparotomy, intraoperative ultrasound 
was carried out in most patients to assess the 
proximity and position of the tumor in relation to 
major remaining vessels and confirm a tumor-free 
left lateral lobe. The first operation was portal vein 
ligation and in situ splitting. The right branch of 
portal vein was dissected and ligated.  Portal, arterial 
and biliary segment IV branches were identified and 
divided. Total or nearly total parenchymal dissection 
along the falciform ligament was performed using 
bipolar forceps and continuous irrigation with saline 
solution. The middle hepatic vein was divided during 
the parenchymal transection. After in situ splitting, 
the abdomen was drained and closed. During the 
second operation, the right artery, right bile duct 
and the right hepatic vein were ligated. Remaining 
parenchymal bridges of liver tissue with vena cava 
and diaphragm, if present, were divided. The liver 
resection was then completed.
There were 22 male (56.4%) and 17 female 
(43.6%). At the time of the first operation, the median 
age was 57.3 years (range: 20-83 years). The most 
common indication was liver metastasis in 32 patients 
(82.0%), followed by cholangiocarcinoma in three 
patients (7.7%), sarcoma in two patients (5.1%) and 
liver cystic disease and hepatocelular carcinoma (one 
patient each, 5.2%). All patients were noncirrhotic. 
Preoperative volumetry was performed in 28 patients 
(71.7%) and all patients had normal liver function 
before resection. In patients who have undergone 
chemotherapy, the chemotherapeutic agent was 
discontinued at least four weeks before surgery. 
RESULTS
The first operation (PVL and ISS) was performed 
in 39 patients. However two patients died (5.2%) 
during this period and did not undergo the second 
operation. An 83 years old male developed severe 
inflammatory response and died twelve days later. 
The second patient with angiosarcoma had multiples 
metastasis in the interval between the first and the 
second operation and died six days later. In this same 
period 262 liver resections were carried out in these 
medical institutions (11.4% was ALPPS). 
The mean interval between the first and 
the second operation was 14.1 days (range: 5-30 
days). The preoperative volumetry was performed 
in 28 patients (71.7%). In those patients who had 
preoperative volumetry, the mean volume of the 
left lateral segment of the liver had increased 83% 
(range 47-211.9%). In one patient was not performed 
the liver transection (ISS) during the first operation, 
just two lines of radiofrequency ablation along the 
falciform ligament. 
Fibrin sealant was used on the raw surface after 
in situ splitting in 18 patients (46.1%) and plastic 
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bag in eight patients (20.5%). In two patients (5.1%) 
the ALPPS was performed totally laparoscopic. Was 
performed at the same time in the first operation 
a pancreaticoduodenectomy in one patient and a 
transverse colectomy in another. During the second 
operation was also performed a rectosigmoidectomy 
in one patient. Nine patients (23.0%) received intra-
operative blood transfusion (1-4 units). 
Significant morbidity after ALPPS was seen in 
23 patients (59.0%). Minor complications occurred 
in some patients. Most patients had more than one 
complication. Complications such as hepatic artery 
thrombosis, acute liver failure, acute renal failure and 
sepsis were responsible for mortality (Table 1).
The average length of stay in the intensive care 
unit was nine days. The mortality rate was 12.8% (five 
patients) including two patients who did not perform 
the second operation. One patient developed 
acute liver failure after hepatic artery thrombosis. 
The second patient developed acute renal failure 
followed by sepsis and the third patient presented 
with postoperative biliary fistula. This was followed 
by peritonitis and sepsis. All of them died of multi-
organ failure. The total length of stay was 17.8 days 
(range: 13-40 days).  
    DISCUSSION
For patients with hepatic primary tumor or 
metastasis from other primary cancers the only 
chance to obtain long-term survival is complete 
tumor resection. The remaining liver volume is still 
one important limiting factor to perform major liver 
resections. Portal vein embolization or ligation are 
able to induce liver hypertrophy of 25-40% after three 
to eight weeks. However, the embolization of segment 
IV branch requires optimal access, may frequently be 
incomplete and is not available in many centers. In 
some patients sufficient hypertrophy of the future 
liver remnant is not always achieved and there is still 
concern about the potential for simultaneous tumor 
progression after portal vein embolization during the 
period prior to resection 4,7,13,18. In ALPPS approach, the 
portal vein ligation associated with in situ splitting is 
able to induce enormously accelerated hypertrophy.
The neovascularisation and persistence 
of interlobar perfusion are prevented by 
performing parenchymal dissection and complete 
devascularization of segment IV. The nearly 
total parenchymal dissection induced a median 
hypertrophy of 74%, which is markedly above the 
range that can be achieved by portal vein ligation or 
portal vein embolization alone14,15,16,17. In the present 
study we observed hypertrophy up to 200%.  
The median time interval to have hypertrophic 
effect is nine days. De Santibanes et al observed a 
rapid growth of the future liver remnant up to 83% 
in only six days. In contrast, hypertrophy using portal 
vein ligation or portal vein embolization is generally 
after four weeks and achieved a much lower degree 
of hypertrophy 3,7,11,14,15,16.. Although some patients in 
this study have performed the second operation in 30 
days, the mean interval between the first and second 
operation was 14 days.   
An important point to promote accelerated 
hypertrophy must be attributed to the in situ 
splitting procedure.  This technique leads to 
complete devascularization of segment IV and also 
prevents formation of vascular collaterals between 
the left lateral and the right extended liver lobe. 
This combination of portal vein ligation and in situ 
splitting is able to induce a much stronger stimulus 
leading to rapid and marked hypertrophy of the left 
lateral lobe. The in situ splitting causes disruption 
on intrahepatic portal collaterals leading to a portal 
flow deprivation to the excluded segments and 
redistribution of hepatotrophic factors15,16,17. In one 
patient was not performed in situ splitting (ISS) during 
the first operation, but just two lines of radiofrequency 
ablation along the falciform ligament. In this patient 
was observed a hypertrophy of 94.5% in 21 days. The 
radiofrequency has been used in liver resections12. 
In spite of the excluded liver does not have any 
portal flow, it acts as an auxiliary liver that contributes 
to the total liver function until the contralateral lobe 
has grown enough to tolerate the physiological 
function like a normal liver14,15,16,17.
The morbidity after this extended liver resection 
depends on the liver and patient condition at 
the time of surgery. The extent of resection and 
underlying disease are also important. Schnitzbauer 
et al.17 observed 64% of complications. Fifty percent 
were classified as grade I or II. We observed a high 
morbidity and mortality of 12.8% (five patients). 
Acute liver failure, acute renal failure and infectious 
complications were those responsible for mortality. 
Schnitzbauer et al.17 reported a perioperative mortality 
rate of 12% (3 patients of 25) which is similar to our 
study. 11 It is a new procedure and still has high rates 
of morbidity and mortality. A second operation within 
a short period of time with a significant inflammatory 
syndrome has been a concern. Adequate patient 
selection is important, particularly those younger and 
TABLE 1 - Complications after ALPPS approach
Complications n %
Surgical site infection 8 20.5
Ascites 5 12.8
Biliary fistula 4 10.2
Pneumonia 4 10.2
Abdominal hernia 4 10.2
Sepsis 3 7.7
Acute renal failure 2 5.1
Bile duct injury 1 2.5
Hepatic artery thrombosis 1 2.5
Acute liver failure 1 2.5
Others 9 23.0
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without comorbidities. In hilar cholangiocarcinoma, 
the jaundice and possible biliary infection cause a 
negative impact on survival. ALPPS is a safe procedure, 
but technically complex and should be undertaken by 
experienced hepatobiliary surgeons14,15,16,17.
The use of fibrin sealant or plastic bag on the 
raw surface or around the liver to avoid adhesions 
is another point of interest and concern. Bioactive 
sealants have the advantage that they do not have 
to be removed. Wrapping of the whole right lobe 
cannot be recommended because of the possible 
undrained fluid collections within the bag. Plastic 
bag can be hazardous because sometimes the 
second stage needs to be postponed due to clinical 
complications or because sufficient hypertrophy of 
the liver remnant has not been achieved. In some 
cases, the second stage may never occur and the 
patient will need a reoperation to remove the bag. 
One of the authors performed two procedures totally 
by laparoscopy with minor adhesions based on his 
previous experience8,9,10.  
Simultaneous surgery for primary colorectal 
tumor with synchronous liver metastasis has been 
showed to be safe and effective. Likewise, in selected 
patients, liver resection can also be performed 
simultaneously with pancreaticoduodenectomy for 
cholangiocarcinoma. In the patient who will undergo 
ALPPS, it can performed simultaneously, without 
mortality1,6.
 This and other experiences should stimulate 
further basic scientific research to answer some 
questions related to liver regeneration, tumor 
molecular biology and biochemical analysis. These 
studies can have the opportunity in the future to 
explain these unsolved questions nowadays. The 
adequate selection of the patient who might benefit 
from this approach must be taken into account. In this 
and others studies ALPPS was able to induce much 
more pronounced and rapid tissue increase in future 
liver remnant for patients with marginally resectable 
liver tumors14,15,16,17. 
CONCLUSION
The ALPPS approach can enable resection 
in patients with lesions previously considered 
unresectable. It induces rapid liver hypertrophy 
avoiding liver failure in most patients. However still 
has high morbidity and mortality.
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